| Application no. and date | 13744668.8 (espacenet) (Federated) (European Patent Register), 20130702 | | Patent/reg. no. and date | DK/EP 2885397, 20180530 | | Publication date | 20150624 | | Priority no. and date | FR 1256329, 20120702 | | EP pub. no. and date |
EP 2885397 20150624 | | Effective date | | | Applicant/owner | Sanofi Pasteur, 14 espace Henry Vallée
69007 Lyon, FR | | Applicant ref. no. | SAN PM1206-EP-EPT | | Inventor | LOUBIERE, Pascal, 9 chemin de Pellegri
F-31450 Donneville, FR,
BARBIRATO, Fabien, 5 rue Victor Hugo
F-69530 Brignais, FR,
LINDLEY, Nicholas, La Vergnerie basse
F-81310 Parisot, FR,
LE HIR, Jérome, 36 rue des Filatiers
F-31000 Toulouse, FR | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/102 (2006.01) , C12N 1/20 (2006.01) , C12P 19/04 (2006.01) | | Title | FREMGANGSMÅDE TIL PRODUKTION AF HAEMOPHILUS INFLUENZAE TYPE B-ANTIGENER | | Int. application no. | FR2013051549 | | Int. publication no. | WO2014006318 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
